Quick Answer
Cellebrite DI Ltd. reported Research And Development Expense of $113.88 million for the year ending 2025.
- Cellebrite DI Ltd. showed an increase of +15.7% in Research And Development Expense from 2024 to 2025.
- This data is from Cellebrite DI Ltd.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Cellebrite DI Ltd.'s Research And Development Expense has grown by 144.5%.
- Historical annual values: Fiscal year 2025: $113.88 million | Fiscal year 2024: $98.42 million | Fiscal year 2023: $84.39 million | Fiscal year 2022: $80.62 million | Fiscal year 2021: $65.54 million | Fiscal year 2020: $54.38 million | Fiscal year 2019: $46.57 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: